Pharmacology
 |
|
22 september 2017 18:00:10 |
| Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet? (Pharmacogenomics Journal) |
|
Tweet |
| 179 viewsCategory: Genomics, Pharmacology |
 Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes (Pharmacogenomics Journal)Chronic fluoxetine upregulates activity, protein and mRNA levels of cytosolic phospholipase A2 in rat frontal cortex (Pharmacogenomics Journal) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
